| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $427.8M | — |
| Cost of Revenue | $126.4M | — |
| R&D Expense | $46.7M | — |
| SG&A Expense | $72.0M | — |
| Operating Income | -$43.3M | — |
| Interest Expense | $817K | — |
| Pre-tax Income | -$51.9M | — |
| Income Tax | -$5.1M | — |
| Net Income | -$46.8M | — |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $154.7M | +116.4% |
| Accounts Receivable | $212.5M | +18.2% |
| Current Assets | $427.2M | +50.1% |
| Total Assets | $2.22B | +43.7% |
| Current Liabilities | $545.7M | +55.3% |
| Long-term Debt | $462.2M | -9.4% |
| Total Liabilities | $836.8M | — |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.2M | — |
| Capital Expenditures | $6.3M | — |
| Investing Cash Flow | -$571.6M | — |
| Financing Cash Flow | $425.4M | — |
| Free Cash Flow | $21.9M | — |
| EPS (Basic) | -$0.35 | — |
| EPS (Diluted) | -$0.35 | — |
| Stockholders' Equity |
| $1.06B |
| +82.8% |